| |
 |
|
Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6127357 |
N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides |
Oct. 3, 2000 |
| 6124330 |
N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines |
Sep. 26, 2000 |
| 6124302 |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
Sep. 26, 2000 |
| 6124283 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Sep. 26, 2000 |
| 6124306 |
Thioalkyl alpha substituted pyrimidine compounds |
Sep. 26, 2000 |
| 6121261 |
Method for treating attention deficit disorder |
Sep. 19, 2000 |
| 6121260 |
Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives |
Sep. 19, 2000 |
| 6114333 |
2-Pyrimidineamine derivatives and processes for their preparation |
Sep. 5, 2000 |
| 6103719 |
Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
Aug. 15, 2000 |
| 6100262 |
(2-morpholinylmethyl) benzamide derivatives |
Aug. 8, 2000 |
| 6096739 |
Treatment for CNS injuries |
Aug. 1, 2000 |
| 6096753 |
Substituted pyrimidinone and pyridone compounds and methods of use |
Aug. 1, 2000 |
| 6087357 |
Piperazine derivatives as tachykinin antagonists |
Jul. 11, 2000 |
| 6083945 |
Cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
Jul. 4, 2000 |
| 6083949 |
Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
Jul. 4, 2000 |
| 6080738 |
Heterocyclic amide compounds and medicinal uses thereof |
Jun. 27, 2000 |
| 6060469 |
Spiro-piperidine derivatives and their use as tachykinin antagonists |
May. 9, 2000 |
| 6060454 |
Compositions, apparatus and methods for facilitating surgical procedures |
May. 9, 2000 |
| 6057323 |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
May. 2, 2000 |
| 6054457 |
Benzamide derivatives and their use as vasopressin antagonists |
Apr. 25, 2000 |
| 6051572 |
Azetidine, pyrrolidine and piperidine derivatives |
Apr. 18, 2000 |
| 6048866 |
Substituted 2-anilinopryimidines useful as protein kinase inhibitors |
Apr. 11, 2000 |
| 6048841 |
Peptidyl compounds |
Apr. 11, 2000 |
| 6015812 |
N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
Jan. 18, 2000 |
| 6008223 |
Therapeutic compounds |
Dec. 28, 1999 |
| 6001835 |
Inhibitors of farnesyl-protein transferase |
Dec. 14, 1999 |
| 5994347 |
For a process for treatment of anxiety and tension |
Nov. 30, 1999 |
| 5990114 |
Use of 5-HT.sub.1A receptor antagonists for the treatment of urinary incontinence |
Nov. 23, 1999 |
| 5990105 |
Benzosulfone derivatives |
Nov. 23, 1999 |
| 5985873 |
Certain substituted benzylamine derivatives a new class of Neuropeptide-Y1 specific ligands |
Nov. 16, 1999 |
| 5981526 |
Use of tachykinin antagonist and rizatriptan |
Nov. 9, 1999 |
| 5981537 |
Pyrimidine-thioalkyl and alkylether compounds |
Nov. 9, 1999 |
| 5977113 |
4-heteroaryl-1-piperazine alkylamines and their therapeutic utility |
Nov. 2, 1999 |
| 5977115 |
Alpha 1a adrenergic receptor antagonists |
Nov. 2, 1999 |
| 5972938 |
Method for treating or preventing psychoimmunological disorders |
Oct. 26, 1999 |
| 5972976 |
Aminostilbazole derivative and medicine |
Oct. 26, 1999 |
| 5968934 |
Morpholine derivatives and their use as therapeutic agents |
Oct. 19, 1999 |
| 5968936 |
Methods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanones |
Oct. 19, 1999 |
| 5968938 |
Piperazine oxytocin receptor antagonists |
Oct. 19, 1999 |
| 5965565 |
Piperidines promote release of growth hormone |
Oct. 12, 1999 |
| 5965559 |
Aminoheterocyclic derivatives as antithrombotic or anticoagulant |
Oct. 12, 1999 |
| 5952330 |
Use of NK-1 receptor antagonists for treating mania |
Sep. 14, 1999 |
| 5948785 |
Heterocyclic amide compounds and pharmaceutical use of the same |
Sep. 7, 1999 |
| 5948777 |
Cannabinoid receptor agonists |
Sep. 7, 1999 |
| 5945413 |
Aspartyl protease inhibitors |
Aug. 31, 1999 |
| 5942508 |
Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid |
Aug. 24, 1999 |
| 5935955 |
Pharmaceutical piperazine compounds |
Aug. 10, 1999 |
| 5935958 |
Muscarinic antagonists |
Aug. 10, 1999 |
| 5932572 |
Topical anti-glaucoma compositions |
Aug. 3, 1999 |
| 5932606 |
Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors |
Aug. 3, 1999 |
|
|
|
